18
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Allogeneic Hematopoietic Stem Cell Transplantation with Non-Myeloablative Conditioning in Patients with Acute Myelogenous Leukemia Eligible for Conventional Allografting: A Prospective Study

, , , , , , & show all
Pages 1191-1195 | Received 03 Nov 2003, Published online: 03 Aug 2009

Reference

  • Tsimberidou, A.M., Stavroyianni, N., Viniou, N., Papaioannou, M., Tiniakou, M., Marinakis, T., et al. (2003) "Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia", Cancer, 97, 1721–1731.
  • Georges, G. and Storb, R. (2003) "Review of "minitransplanta-tion": Nonmyeloablative allogeneic hematopoietic stem cell trans-plantation", International Journal of Hematology, 77, 3–14.
  • Djulbegovic, B., Seidenfeld, J., Bonnell, C. and Kumar, A. (2003) "Nonmyeloablative allogeneic stem-cell transplantation for hema-tologic malignancies: A systematic review", Cancer Control, 10, 17 — 31.
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y. et al. (1998) "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases", Blood, 91, 756–763.
  • Giralt, S., Estey, E., Albitar, M., van Besien, K. et al. (1997) "Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeoablative therapy", Blood, 89, 4531 —4536.
  • Ruiz-Arguelles, G.J., Gómez-Almaguer, D., Ruiz-Arguelles, A., Gonthlez-Llano, 0., Cantil, 0.G. and Jaime-Perez, J.C. (2001) "Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens", American Journal of Hematology, 66, 241–244.
  • Ruiz-Argüelles, G.J., Gómez-Almaguer, D., Lopez-Martinez, B., Cantu-Rodriguez, 0.G., Jaime-Pérez, J.C. and González-Llano, 0. (2002) "Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia", Haematologica, 87, 894–896.
  • Or, R., Shapira, M.Y., Resnick, I., Amar, A., Ackerstein, A., Samuel, S., et al. (2003) "Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase", Blood, 101, 441–445.
  • Martino, R., Giralt, S., Caballero, M.D., Mackinnon, S., Corradini, P., Fernández-Aviles, F., et al. (2003) "Allogeneic hematopoietic stem cell transplantation with reduced-intensity coinditioning in acute lymphoblastic leukemia: A feasibility study", Haematologica, 88, 555–560.
  • Carella, A.M., Beltrami, G, Carella, M. Jr., Corsetti, M.T., Scalzulli, R.P. and Greco, M. (2001) "Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodg-kin's disease", Haematologica, 86, 1121–1123.
  • Ruiz-Argtielles, G.J. (2002) "Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: Results of the Mexican approach", International Journal of Hematology, 76\(Suppl 1) 376–379.
  • Gómez-Almaguer, D., Ruiz-Argtielles, G.J., Tarin-Arzaga, L.C., Gonthlez-Llano, 0., Jaime-Perez, J.C., Lopez-Martinez, B., et al. (2003) "Reduced-intensity stem cell transplantation in children and adolescents: The Mexican experience", Biol. Blood Marrow Transpl., 9, 157 — 161.
  • Kessinger, A., Armitage, J.0., Landmark, J.D., Smith, D.M. and Weisenburger, D.D. (1998) "Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy", Blood, 71, 723–727.
  • Ruiz-Argtielles, A. (1992) "Flow cytometry in the clinical labora-tory. Principles, applications and problems", Annales de Biologie Clinique, 50, 735–743.
  • Ruiz-Arguelles, A. and Orfao, A. (1996) CaracterizaciOn y evalua-ciOn de celulas totipotenciales en sangre periferica y medula Osea. In Actualización en Leucemias edited by Ruiz-Argüelles, G.J., San-Miguel, J.F. Mexico City: Editorial Medica Panamericana. pp. 79 — 82.
  • Pinkel, D., Straume, T. and Gray, J.W. (1986) "Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization", Proceedings of the National Academy of Science USA, 83, 2934 — 2938.
  • Ruiz-Arguelles, G.J., LOpez-Martinez, B., Santellán-Olea, M.R., Abreu-Diaz, G., Reyes-NOriez, V., Ruiz-Arguelles, A., et al. (2002) "Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosup-pressive, non-myeloablative conditioning regimen: A prospective study in a single institution", Leukemia and Lymphoma, 43, 1509 — 1511.
  • Yam, P., Petz, L., Knowlton, R., Wallace, R., Stock, A., deLange, G., et al. (1987) "Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation", Transplantation, 43, 399–407.
  • Ruiz-Argüelles, G.J., Garcés-Eisele, J., Reyes-NOriez, V., Perez-Romano, B., Ruiz-Argtielles, A., Ramirez-Cisneros, F., et al. (2000) "Assessment of residual disease in acute leukemia by means of polymerase chain reaction: A prospective study in a single institution", Rev. Invest. Clin. Mex., 52, 118 — 124.
  • Stone, R.M. (2002) "Treatment of acute myeloid leukemia: State-of-the-art and future directions", Seminars of Hematology, 39\(Suppl 2), 4–10.
  • Ruiz-Arguelles, G.J. and Gómez-Almaguer, D. (2003) "The Mexican approach to conduct non-myeloablative stem cell trans-plantation should not be overlooked", International Journal of Hematology, 77, 526–527.
  • Ruiz-Arguelles, G.J. (2001) —The Mexican approach' to conduct non-myeloablative stem cell transplantation", European Journal of Haematology, 67, 5–6.
  • Martino, R., Caballero, M.D., Simon, J.A., Canals, C., Solano, C., Urbano-Ispizua, A., et al. (2002) "Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell trans-plantation with reduced-intensity conditioning in acute myelogen-ous leukemia and myelodysplastic syndromes", Blood, 100, 2243–2245.
  • Burnett, A.K., Wheatley, K., Goldstone, A.H., Stevens, R.F., Hann, I.M., Rees, J.H., et al. (2002) "The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial", British Journal of Haematology, 118, 385–400.
  • Greinix, H.T., Nachbaur, D., Krieger, 0., Eibl, M., Knobl, P., Kalhs, P., et al. (2002) "Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry", British Journal of Haematology, 117, 914–923.
  • Feinstein Lyle, C., Sandmaier, B.M., Hegenbart, U., McSweeney, P.A., Maloney, D.G., Gooley, T.A., et al. (2003) "Non-myeloa-blative allografting from human leukocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission", British Journal of Haematology, 1209, 281 — 288.
  • Sayer, H.G., Kroger, M., Beyer, J., Kiehl, M., Klein, S.E., Schaefer-Eckart, K., et al. (2003) "Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: Disease status by marrow blasts is the strongest prognostic factor", Bone Marrow Transplantation, 12, 1089 — 1095.
  • Gómez-Almaguer, D. (2002) "The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients", International Journal of Hematology, 76\(Suppl 1), 380–382.
  • Barr, R.D. (2002) "The importance of lowering the costs of stem cell transplantation in developing countries", International Journal of Hematology, 76 U\(Suppl 1), 365–367.
  • Barrett, J.A. (2000) "Conditioning regimens for allogeneic stem cell transplants", Current Opinion in Hematology, 7, 339–342.
  • Ruiz-Arguelles, G.J. (2003) "Non-myeloablative bone marrow transplantation", Archives of Medical Research, in the press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.